Skip to Content


In the US, Icosapent (icosapent systemic) is a member of the drug class miscellaneous antihyperlipidemic agents and is used to treat Hypertriglyceridemia.

US matches:



CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Antiplatelet agent

Lipid lowering agent: Concomitant therapy

Chemical Name

(all-Z)-5,8,11,14,17-eicosapentaenoic acid

Foreign Names

  • Icosapentum (Latin)
  • Icosapent (German)
  • Icosapent (French)
  • Icosapento (Spanish)

Generic Names

  • Icosapent (OS: DCF)
  • Acidum eicosapentaenoicum (IS)
  • Eicosapentaenoic acid (IS)
  • Eicosapentaensäure (IS)
  • EPA (IS)
  • Icosapentaenoic acid (IS)
  • Icosapentsäure (IS)
  • Timnodonsäure (IS)
  • Ethyl Icosapentate (OS: JAN)
  • Icosapent Ethyl (OS: USAN)
  • Ethyl Eicosapentaenoate (IS)
  • Ethyl icosapentaenoat (IS)
  • Ethyl-eicosapentaenoic acid (IS)
  • Ethyl-EPA (IS)
  • Timnodonic acid ethyl ester (IS)
  • Ethyl Icosapentate (PH: JP XVI)

Brand Names


DCFDénomination Commune Française
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.